Shingo Tsuji
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
TAS3351 is a brain penetrable EGFR-TKI that overcomes T790M and C797S resistant mutations.
Journal: Communications medicine
Published: May 13, 2025
Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.
Journal: Scientific reports
Published: August 12, 2023
Tumor stiffness measurement using magnetic resonance elastography can predict recurrence and survival after curative resection of hepatocellular carcinoma.
Journal: Surgery
Published: August 09, 2022
TAS2940, a novel brain-penetrable pan-ERBB inhibitor, for tumors with HER2 and EGFR aberrations.
Journal: Cancer science
Published: August 08, 2022
Validity of the Algorithm for Liver Resection of Hepatocellular Carcinoma in the Caudate Lobe.
Journal: World journal of surgery
Published: December 14, 2021
TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress.
Journal: Communications biology
Published: March 23, 2021
Artificial intelligence-based computational framework for drug-target prioritization and inference of novel repositionable drugs for Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: November 23, 2020
Selection of patients with esophageal varices for liver resection of hepatocellular carcinoma.
Journal: Bioscience trends
Published: October 15, 2020
High platelet count as a poor prognostic factor for liver cancer patients without cirrhosis.
Journal: Bioscience trends
Published: July 28, 2020
High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma.
Journal: Bioscience trends
Published: June 09, 2020
Last Updated: 09/26/2026